Skip to main content

News
& Events

Events

No events scheduled at this time.

Press Releases

June 13, 2023

Comanche Biopharma Strengthens Board of Directors with Appointment of Dr. Ann Taylor

May 12, 2023

Comanche Biopharma Appoints Allyson Felix to Board of Directors

Media Contact

Liz Melone
Melone Communications, LLC
Mobile: +1 617-256-6622
Email: press@comanchebiopharma.com

Contact Us

50 Beharrell St, Unit B
Concord, MA 01742

Contact Us

Comanche is a biopharmaceutical company developing an investigational siRNA medicine for preterm preeclampsia. We envision a world where all women and their babies have access to safe and effective therapies for treating life threatening complications of pregnancy, and those solutions must be evidence-based and affordable.

Sign up to receive email updates

Translate 🌎 💬